Intrafamilial correspondences on platelet [3H-]paroxetine- binding indices in bulimic probands and their unaffected first-degree relatives

Neuropsychopharmacology

Volumn 31, Issue 8, 2006, Pages 1785-1792

  Steiger, Howard ^a,b,c   Gauvin, Lise ^d   Joober, Ridha ^b,c   Israel, Mimi ^a,b,c   Ng Ying Kin, N M K ^b,c   Bruce, Kenneth R ^a,b,c   Richardson, Jodie ^a,b   Young, Simon N ^b   Hakim, Julie ^a  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bulimia nervosa; Endophenotype; Familial traits; Paroxetine binding; Serotonin

Indexed keywords

PAROXETINE; SEROTONIN; TRITIUM;

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR DISORDER; BINDING AFFINITY; BINGE EATING DISORDER; BULIMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EATING DISORDER; FAMILIAL DISEASE; FEMALE; HERITABILITY; HUMAN; LINEAR SYSTEM; MENTAL DISEASE; MOOD DISORDER; MOTHER; PHENOTYPE; PRIORITY JOURNAL; RELATIVE; RISK FACTOR; SAMPLING; SEROTONIN UPTAKE; STATISTICAL MODEL; THROMBOCYTE;

ADOLESCENT; ADULT; BLOOD PLATELETS; BULIMIA NERVOSA; FEMALE; HUMANS; MIDDLE AGED; PAROXETINE; PEDIGREE; PROTEIN BINDING; SEROTONIN; TRITIUM;

EID: 33746322711     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301011     Document Type: Article

References (44)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press: Washington, DC.
2. Bailer UF, Price JC, Meltzer CC, Mathis CA, Frank GK, Weissfeld L et al (2004). Altered 5-HT (2A) receptor binding after recovery from bulimia type anorexia nervosa: relationships to harm avoidance and drive for thinness. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol 29: 1143-1155.
3. Bruce KR, Steiger H, Joober R, Ng Ying Kin NMK, Israel M, Young SN (2005). Association of the promoter polymorphism-1438G/A of the 5-HT2A receptor gene with behavioural impulsiveness and serotonin function in women with bulimia nervosa. Am J Med Genet. Part B (Neuropsychiatr Genet) 137B: 40-44.
4. Bucholz KK, Robins LN, Shayka JJ, Przybeck TR, Heltzer JE, Goldring E et al (1991). Performance of two forms of a computer psychiatric screening interview: Version 1 of the DISSI. J Psychiatry Res 25: 117-129.
5. Carrasco JL, Diaz-Marsa M, Hollander E, Cesar J, Saiz-Ruiz J (2000). Decreased platelet monoamine oxidase activity in female bulimia nervosa. Eur Neuropsychopharmacol: J European Coll Neuropsychopharmacol 10: 113-117.
6. Cowen PJ, Clifford EM, Walsh AES, Williams C, Fairburn CG (1996). Moderate dieting causes 5-HT2C receptor supersensitivity. Psychol Med 26: 1155-1159.
7. Delorme R, Betancur C, Callebert J, Chabana N, Laplanche J-L, Mouren-Simeon M-C (2005). Platelet serotonergic markers as endophenotpyes for obsessive-compulsive disorder. Neuropsychopharmacology 30: 1539-1547.
8. Ellis PM, Salmond C (1994). Is platelet imipramine binding reduced in depression? A meta-analysis. Biol Psychiatry 36: 292-299.
9. Fairburn CG, Beglin SJ (1994). Assessment of eating disorders: interview or self-report questionnaire? Int J Eating Disord 16: 363-370.
10. Fairburn CG, Cooper P (1993). The eating disorders examination. In: Fairburn C, Wilson G (eds). Binge Eating: Nature, Assessment and Treatment, 12th edn. Guilford: New York. pp 317-360.
11. Fairburn CG, Harrison PJ (2003). Eating disorders. Lancet 361: 407-416.
12. Falconer DS, Mackay TFC (1996). An Introduction to Quantitative Genetics, 4th edn. Prentice-all: Essex. pp 161-183.
13. First MB, Spitzer RL, Gibbon M, Williams M, Janet BW, Benjamin L (1997). Structured Clinical Interview for DSM-IV Axis I Disorders. Research Version. Patient Edition. Biometrics Research, New York State Psychiatric Institute: New York.
14. Garner DM, Olmsted M, Bohr Y, Garfinkel P (1982). The eating attitudes test: psychometric features and clinical correlates. Psychol Med 12: 871-878.
15. Gottesman II (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160: 636-645.
16. Huether G, Zhou D, Schmidt S, Wiltfang J, Rüther E (1997). Long-term food restriction down regulates the density of serotonin transporters in the rat frontal cortex. Biol Psychiatry 41: 1174-1180.
17. Jimerson DC, Lesem MD, Kaye WH, Brewerton TD (1992). Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 49: 132-138.
18. Kaye WH, Frank GK, Meltzer CM, Price JC, McConaha CW, Crossan PJ et al (2001). Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. Am J Psychiatry 158: 1152-1155.
19. Kaye WH, Greeno CG, Moss H, Fernstrom JD, Fernstrom MH, Lilenfeld LR et al (1998). Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa. Arch Gen Psychiatry 55: 927-935.
20. Leboyer M, Quintin P, Manivet P, Varoquaux O, Allilaire J-F, Launay J-M (1999). Decreased serotonin treasnporter binding in unaffected relatives of manic depressive patients. Biol Psychiatry 46: 1703-1706.
21. Lesch KP, Wolozin BL, Murphy DL, Reiderer P (1993). Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 60: 2319-2322.
22. Levitan RD, Kaplan AS, Joffe RT, Levitt AJ, Brown GM (1997). Hormonal and subjective responses to intravenous metachlorophenylpiperazine in bulimia nervosa. Arch Gen Psychiatry 54: 521-527.
23. Livesley WJ, Jackson DN, Schroeder ML (1992). Factorial structure of traits delineating personality disorders in clinical and general population samples. J Abnormal Psychol 101: 432-440.
24. Mann J, Huang Y, Underwood M, Kassir S, Oppenheinm S, Kelly T et al (2000). A serotonin trasnporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57: 729-738.
25. Marazziti D, Macchi E, Rotondo A, Placidi GF, Cassano GB (1988). Involvement of the serotonin system in bulimia. Life Sci 43: 2123-2126.
26. Nishiguchi N, Matsushita S, Suzuki K, Murayama M, Shirakawa O, Higuchi S (2001). Association between 5HT2A receptor gene promoter region polymorphism and eating disorders in Japanese patients. Biol Psychiatry 50: 123-128.
27. Nobile M, Begni B, Giorda R, Alessqandro F, Marino C, Molteni M et al (1999). Effects of serotonin transporter promoter genotype on platelet serotonin transporter functionality in depressed children and adolescents. J Am Acad Child Adolesc Psychiatry 38: 1396-1402.
28. Patton JH, Stanford MS, Barrat ES (1995). Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol 51: 768-774.
29. Pratt EM, Niego SH, Agras SW (1998). Does the size of a binge matter? Int J Eating Disord 24: 307-312.
30. Raudenbush SW, Bryk AS (2002). Hierarchical Linear Models: Applications and Data Analysis Methods, 2nd edn. Sage: Thousand Oaks.
31. Rausch J, Johnson ME, Li J, Hutcheson J, Carr BM, Corley KM et al (2005). Serotonin transport kinetics correlated between human platelets and brain synaprosomes. Psychopharamacology 180: 391-398.
32. Smith KA, Fairburn CG, Cowen PJ (1999). Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. Arch Gen Psychiatry 56: 171-176.
33. 3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers. Biol Psychiatry 43: 774-780.
34. Steiger H (2004). Eating disorders and the serotonin connection: State, trait and developmental effects. J Psychiatry Neurosci: JPN 29: 20-29.
35. Steiger H, Gauvin L, Israël M, Ng Ying Kin NMK, Young SN, Roussin J (2004). Serotonin function, personality-trait variations and childhood abuse in women with bulimia-spectrum eating disorders. J Clin Psychiatry 65: 830-837.
36. 3H-]paroxetine binding in bulimic syndromes. Int J Eating Disord 37: 57-60.
37. Steiger H, Koerner NM, Engleberg M, Israël M, Ng Ying Kin NMK, Young SN (2001). Self-destructiveness and serotonin function in bulimia nervosa. Psychiatry Res 103: 15-26.
38. Steiger H, Leonard S, Ng Ying Kin NMK, Ladouceur C, Ramdoyal D, Young SN (2000). Childhood abuse and tritiated paroxetine binding in bulimia nervosa. J Clin Psychiatry 61: 428-435.
39. 3H-] paroxetine in remitted bulimic women. Neuropsychopharmacology 30: 1028-1032.
40. Steiger H, Young SN, Kin NM, Koerner N, Israel M, Lageix P et al (2001). Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa. Psychol Med 31: 85-95.
41. Tauscher J, Pirker W, Willeit M, de Zwaan M, Bailer U, Neumeister A et al (2001). Beta-CIT and single photon emission computer tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biol Psychiatry 49: 326-332.
42. Waller DA, Sheinberg AL, Gullion C, Moeller FG, Cannon DS, Petty F et al (1996). Impulsivity and neuroendocrine response to buspirone in bulimia nervosa. Biol Psychiatry 39: 371-374.
43. Weathers FW, Keane TM, Davidson JRT (2001). Clinician-administered PTSD scale: a review of the first ten years of research. Depression Anxiety 13: 132-156.
44. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ (1977). Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 106: 203-214.